Ilika plc with ticker (LON:IKA) now has a potential upside of 226.3% according to Berenberg Bank.
Berenberg Bank set a target price of 120 GBX for the company, which when compared to the Ilika plc share price of 37 GBX at opening today (19/01/2024) indicates a potential upside of 226.3%. Trading has ranged between 25 (52 week low) and 72 (52 week high) with an average of 231,232 shares exchanging hands daily. The market capitalisation at the time of writing is £58,479,174.
Ilika plc is a United Kingdom-based company. The Company is engaged in developing and commercializing its cutting-edge solid-state batteries. The Company develops and commercializes its thin-film Stereax miniature solid-state batteries for powering implantable medical devices and industrial wireless sensors (IIoT) in specialist environments, as well as progressing the development of its large-format Goliath cells for electric vehicles (EV) and cordless appliances. It has a secured lease of approximately 1,600 square meters property for Stereax manufacturing scale-up and installed over 340 square meters clean room facility. The Company is enabling solutions for applications, such as industrial Internet of things (IoT), MedTech, electric vehicles (EV) and consumer electronics. The Company has its operations in the United States of America, China and Israel.
Ilika plc 226.3% potential upside indicated by Berenberg Bank
- Written by: Charlotte Edwards
Find more news, interviews, share price & company profile here for:
Latest Company News
Ilika’s Goliath batteries are being scaled with standard lithium-ion tools and low-cost materials to match today’s battery economics.
Take a look back at Ilika’s 2025 progress, as the company moved from laboratory validation to manufacturing, delivering key Stereax and Goliath solid-state battery milestones.
Ilika plc CEO Graeme Purdy confirms that the Stereax M300 — their miniature solid-state battery — is now in commercial production via Cirtec Medical in the US. With 21 customers lined up and applications ranging from pain neurostimulators to smart orthodontics, this marks a major milestone for the company.
Ilika’s new 10 amp-hour solid-state cells point to a shift from lab validation to scalable, real-world relevance.
Ilika has begun shipping prototype Stereax M300 solid state batteries to customers, marking a key commercial milestone for the company.
Ilika's Graeme Purdy discusses scaling the Goliath solid-state battery to 10Ah, the role of the automated pilot line, manufacturing yields, and how this work supports future 50Ah development.
